Literature DB >> 1965117

The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases.

T Sorsa1, K Suomalainen, V J Uitto.   

Abstract

Interstitial collagenases (matrix metalloproteinase-1, EC 3.4.24.7), isolated from extracts of inflamed human gingiva, gingival crevicular fluid and saliva were characterized for their molecular weight, proteolytic and non-proteolytic activation and substrate specificity against soluble collagen types I, II and III. All three collagenases had Mr of 70 K. The enzymes existed predominantly in a latent form that could be activated by aminophenylmercuric acetate, gold thioglucose and hypochlorous acid. Among serine proteases tested, trypsin, chymotrypsin, neutrophil cathepsin G and a combination of trypsin and human gingival fibroblast prostromelysin activated gingival and salivary interstitial collagenases. Plasmin and plasma kallikrein, however, were relatively ineffective activators. The collagenases degraded soluble type I and II collagens at apparently equal rates but considerably faster than they did type III collagen. These findings suggest that the characteristics of interstitial collagenases found in inflamed human gingiva, gingival crevicular fluid and saliva are consistent with those of human neutrophil interstitial collagenase rather than the fibroblast-type interstitial collagenase. Thus, neutrophils are suggested to be the main source of such enzymes in inflamed human gingiva, crevicular fluid and saliva during adult periodontitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965117     DOI: 10.1016/0003-9969(90)90156-5

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  12 in total

1.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Current developments in salivary diagnostics.

Authors:  Craig S Miller; Joseph D Foley; Alison L Bailey; Charles L Campell; Roger L Humphries; Nicolaos Christodoulides; Pierre N Floriano; Glennon Simmons; Bryon Bhagwandin; James W Jacobson; Spencer W Redding; Jeffrey L Ebersole; John T McDevitt
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 5.  Proteomics - The research frontier in periodontics.

Authors:  Abhaya Gupta; Vivek Govila; Ashish Saini
Journal:  J Oral Biol Craniofac Res       Date:  2015-02-25

6.  Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis.

Authors:  Balwant Rai; Jasdeep Kaur; Rajnish Jain; Suresh C Anand
Journal:  Saudi Dent J       Date:  2010-04-14

7.  Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases.

Authors:  T Sorsa; T Ingman; K Suomalainen; M Haapasalo; Y T Konttinen; O Lindy; H Saari; V J Uitto
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Host-bacteria crosstalk at the dentogingival junction.

Authors:  M T Pöllänen; M A Laine; R Ihalin; V-J Uitto
Journal:  Int J Dent       Date:  2012-07-26

Review 9.  Salivary Antimicrobial Peptides in Early Detection of Periodontitis.

Authors:  Güliz N Güncü; Dogukan Yilmaz; Eija Könönen; Ulvi K Gürsoy
Journal:  Front Cell Infect Microbiol       Date:  2015-12-24       Impact factor: 5.293

10.  Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.

Authors:  Chao Yuan; Xiaochen Liu; Shuguo Zheng
Journal:  BMC Oral Health       Date:  2018-03-27       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.